Pulmonary fibrosis: from pathogenesis to clinical decision-making
T Koudstaal, M Funke-Chambour, M Kreuter… - Trends in molecular …, 2023 - cell.com
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that
progressively impact the interstitium, resulting in compromised gas exchange …
progressively impact the interstitium, resulting in compromised gas exchange …
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
TM Drake, AB Docherty, EM Harrison… - American journal of …, 2020 - atsjournals.org
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase …
Background The use of cyclophosphamide in patients with acute exacerbation of idiopathic
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …
Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations
T Shao, X Shi, S Yang, W Zhang, X Li, J Shu… - Frontiers in …, 2021 - frontiersin.org
Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …
Acute exacerbation of interstitial lung disease associated with rheumatic disease
F Luppi, M Sebastiani, C Salvarani… - Nature Reviews …, 2022 - nature.com
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2, has affected virtually all aspects of patient care. Health-care …
syndrome coronavirus 2, has affected virtually all aspects of patient care. Health-care …
Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis
CN D'Alessandro-Gabazza, T Yasuma… - Nature …, 2022 - nature.com
Idiopathic pulmonary fibrosis is an incurable disease of unknown etiology. Acute
exacerbation of idiopathic pulmonary fibrosis is associated with high mortality. Excessive …
exacerbation of idiopathic pulmonary fibrosis is associated with high mortality. Excessive …
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 …
JA Mackintosh, G Keir, LK Troy, AE Holland… - …, 2024 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …
Idiopathic pulmonary fibrosis
F León-Román, C Valenzuela… - Medicina Clínica (English …, 2022 - Elsevier
Idiopathic pulmonary fibrosis is defined as a chronic progressive fibrosing interstitial
pneumonia of unknown etiology. There are intrinsic and extrinsic risk factors that could favor …
pneumonia of unknown etiology. There are intrinsic and extrinsic risk factors that could favor …